Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1984;64:381-385
© 1984 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PETERS, F.
Right arrow Articles by BRECKWOLDT, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PETERS, F.
Right arrow Articles by BRECKWOLDT, M.

Serum Prolactin Levels in Patients With Fibrocystic Breast Disease

F. PETERS, MB, W. SCHUTH, MD, B. SCHEURICH and M. BRECKWOLDT, MD

From the Department of Obstetrics and Gynecology, University of Freiburg, Freiburg, Federal Republic of Germany.

Abstract

In 193 patients suffering from fibrocystic breast disease, basal serum prolactin concentrations were determined and compared to serum prolactin levels in 193 healthy women. In 45 additional patients and 23 healthy control subjects, a thyrotropin-releasing hormone (TRH) stimulation test was performed. The response to TRH in seven healthy female volunteers and in one patient with fibrocystic breast disease, was correlated with the mean serum prolactin levels over 24 hours. Serum prolactin levels were above normal in 45.6% of the patients and in 21.2% of the control subjects. Mean values of the two groups were significantly different (P < .001). The maximum prolactin response to TRH stimulation was significantly higher in the study patients than in the control subjects (P < .001). The TRH-stimulated prolactin response correlated positively with the mean 24-hour level (P < .01, r = 0.8705). These results indicate that a high proportion of patients with fibrocystic breast disease exhibit increased daily prolactin secretion.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
F. Peters, P. Diemer, O. Mecks, and L. J. Behnken
Severity of Mastalgia in Relation to Milk Duct Dilatation
Obstet. Gynecol., January 1, 2003; 101(1): 54 - 60.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S Gill, D Peston, B K Vonderhaar, and S Shousha
Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study
J. Clin. Pathol., December 1, 2001; 54(12): 956 - 960.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American College of Obstetricians and Gynecologists.